Antibiotics

Catalog Product Name / CAS / Description Structure
BBF-02154

Pyrromycin (668-17-7)

Inquiry

It is an antibiotic against gram-positive bacteria originally isolated from Str. sp. DOA 1205.

BBF-02155

Pyrronamycin A is produced by the strain of Streptomyces sp. KY11768. It has antibacterial activity against gram-positive and negative bacteria such as Staphylococcus aureus, enterococcus, Escherichia coli, Klebsiella pneumoniae, Proteus, Shigella and Salmonella.

BBF-02156

Pyrronamycin B is produced by the strain of Streptomyces sp. KY11768. It has antibacterial activity against gram-positive and negative bacteria such as Staphylococcus aureus, enterococcus, Escherichia coli, Klebsiella pneumoniae, Proteus, Shigella and Salmonella. It also has anti-tumor activity.

BBF-02157

Isoquinocycline A is originally isolated from Str. aureofaciens. It has strong anti-mycobacterium activity.

BBF-02158

Quadrilineatin (642-27-3)

Inquiry

It is originally isolated from Asp. quadrilineatus NRRL 521, NRRL 201, SM 200, SM-297, GA317. Quadrilineatin has antifungal and bacterial effects.

BBF-02160

Queenslandon is produced by the strain of Chrysosporium queenslandicum IFM 51121. It has moderate anti-streptomyces, penicillium, Penicillium, Aspergillus fumigatus, aspergillus flavus and other fungal activities. And it has no effect on bacteria.

BBF-02165

Quinomycin C (11001-74-4)

Inquiry

Quinomycin C is originally isolated from Str. sp. 732. It has a strong effect on gram-positive bacteria and HeLa cells, and also on some gram-negative bacteria. It also has a protective effect on mice inoculated with poliovirus.

BBF-02166

Quinomycin B (13602-52-3)

Inquiry

Quinomycin B is originally isolated from Str. sp. 732. It has a strong effect on gram-positive bacteria and HeLa cells, and also on some gram-negative bacteria. It also has a protective effect on mice inoculated with poliovirus.

BBF-02167

Rabelomycin is originally isolated from Str.olivaceus. Rabelomycin only works against gram-positive bacteria.

BBF-02168

Racemomycin A (3808-42-2)

Inquiry

It is produced by the strain of Str. racemochromogenes 229. It has broad spectrum antibacterial activity and antifungal effect, and it can inhibit PR-8 of influenza virus in tissue culture.

BBF-02169

Racemomycin B (3776-37-2)

Inquiry

It is produced by the strain of Str. racemochromogenes 229. It has broad spectrum antibacterial activity and antifungal effect, and it can inhibit PR-8 of influenza virus in tissue culture.

BBF-02170

Racemomycin C (3776-38-3)

Inquiry

It is produced by the strain of Str. racemochromogenes 229. It has broad spectrum antibacterial activity and antifungal effect, and it can inhibit PR-8 of influenza virus in tissue culture.

BBF-02171

Racemomycin D (3776-36-1)

Inquiry

It is produced by the strain of Str. racemochromogenes 229. It has broad spectrum antibacterial activity and antifungal effect, and it can inhibit PR-8 of influenza virus in tissue culture.

BBF-02172

Radicinin (10088-95-6)

Inquiry

Radicinin is produced by the strain of Curvularia lunata IAM-18010. It has anti-bacterial effect, but its activity is weak.

BBF-02173

Rakicidin A is originally isolated from Micromonospora sp. R385-2. It has anti-tumor activity in vitro with the IC50 of 40 μg/mL.

BBF-02174

Rakicidin B is originally isolated from Micromonospora sp. R385-2. It has anti-tumor activity in vitro with the IC50 of 200 μg/mL.

BBF-02175

Ramulosin (29914-01-0)

Inquiry

It is produced by the strain of Pestalotia ramulosa NRRL 2826. Ramulosin has an antifungal effect and inhibits the germination of fungal meristems.

BBF-02176

Rancinamycin III (60925-60-2)

Inquiry

Rancinamycin III is an antibiotic that has antibacterial properties originally isolated from Str. lincolnensis.

BBF-02178

It is produced by the strain of Streptomyces sp. GW71/2497. Resomycin A showed activity of anti-staphylococcus aureus, Escherichia coli and Streptomyces green, with MIC of about 20 μg/mL.

BBF-02179

It is produced by the strain of Streptomyces sp. GW71/2497. Resomycin B showed activity of anti-staphylococcus aureus, Escherichia coli and Streptomyces green, with MIC of about 20 μg/mL.

Copyright © 2024 BOC Sciences. All rights reserved.

cartIcon
Inquiry Basket